Merck & Co., Inc. (MRK)
NYSE · Common · CUSIP 58933Y105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for MRK and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
58933Y105 (prev. 589331107 )
Market Cap
Large Cap
Previous Name
Merck Sharp & Dohme Corp.
Business: Merck & Co., Inc., is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. The Company provides prescription medicines, vaccines, biologic therapies, and consumer care and animal health products to more than 140 countries to deliver innovative health solutions.
Notes: November 3, 2009 -- Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they will complete their merger shortly after 4:00PM ET today. The companies will begin combined operations tomorrow, November 4, 2009. As previously announced, Schering-Plough will change its name to Merck and its common stock will trade under the ticker symbol “MRK” on the New York Stock Exchange. Under the terms of the agreement, Schering-Plough shareholders will receive 0.5767 shares of the newly combined company and $10.50 in cash for each share of Schering-Plough. Each Merck common share will automatically become a common share of the newly combined company.

Company Contact

CEO
Robert M. Davis
CFO
Caroline Litchfield
Headquarters
126 East Lincoln Avenue, Rahway , NJ 07065
Phone
908-740-4000 · Toll-Free 800-225-5675
Investor Relations
Peter Dannenbaum · 908-740-1037 · investor_relations@merck.com
Email Form
Material Request Form »
SEC EDGAR Filings
View filings »
Find all related securities for MRK »